If you have been reading about WADA and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-01-09. Numbers and descriptions here follow the published literature rather than marketing material.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | SR9009; Stenabolic | Nickname is not a chemical name. |
| Typical analytical method | LC-MS/MS | Often with isotope-labeled internal standard. |
| Storage temperature | -20 °C | Desiccated and protected from light. |
| Solution stability | DMSO stock; avoid freeze-thaw | Store at -20 to -80 °C. |
| Regulatory status | Not approved; varies by country | May be restricted as research chemical. |
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
The precise reason why there are only four nucleotides is debated, but there are several unused possibilities. Furthermore, adenine is not the most stable choice for base pairing: in Cyanophage S-2L, diaminopurine (DAP) is used instead of adenine. Diaminopurine basepairs perfectly with thymine as it is identical to adenine but has an amine group at position 2 forming 3 intramolecular hydrogen bonds, eliminating the major difference between the two types of basepairs (weak A-T vs strong C-G). This improved stability affects protein-binding interactions that rely on those differences. Other combination include:
Emerging applications include regenerative approaches based on tissue engineering, where injectable scaffolds combined with cells or bioactive components aim to promote the formation of new extracellular matrix and restore tissue function, or to act as delivery systems for therapeutic agents. Cell-laden hydrogels support tissue regeneration by protecting encapsulated cells and enhancing their survival, while protein-loaded systems enable sustained release of growth factors such as vascular endothelial growth factor (VEGF) and bone morphogenetic proteins, promoting angiogenesis and bone repair. Drug-loaded hydrogels have also been developed for localized therapies, including cancer treatment, cartilage regeneration, and myocardial repair, where controlled release improves efficacy and reduces systemic side effects.
== Research == A 2003 systematic review found that kava extract reduced anxiety symptoms compared to placebo, with a small effect size and mostly mild, transient side effects. Kava may help with anxiety after several weeks of use. Meta-analyses suggest kava can reduce anxiety symptoms – sometimes comparably to medications like oxazepam and buspirone – with strongest evidence seen in multiweek studies using aqueous extracts for generalized anxiety disorder, although results were mixed and standardized trials are limited. Current evidence does not support its effectiveness for generalized anxiety disorder or other conditions. Kava has no proven effects on cancer, cognitive function, or microbial infections. Kava generally does not impair cognition at therapeutic doses and may enhance attention and memory at lower doses, but may reduce visual attention at higher or recreational doses; heterogeneity in study design, dosage, preparation, and small sample sizes limits definitive conclusions. A study of heavy and long-term kava users in northern Australia found no evidence of cognitive or brain dysfunction despite some physical health effects, including liver enzyme elevation and skin changes.
The route of administration has only a slight effect on the drug's concentrations in the bloodstream: when given as an intramuscular injection, its bioavailability is 90% (as compared to the 100% availability when given directly into a vein), and its highest concentrations in the blood plasma are reached after about 2.3 hours. In the blood, 85–95% of ertapenem are bound to plasma proteins, mostly albumin. Plasma protein binding is higher for lower concentrations, and vice versa. The drug is only partially metabolized, with 94% circulating in form of the parent substance and 6% as metabolites. The main metabolite is the inactive hydrolysis product with the ring opened. Ertapenem is mainly eliminated via the kidneys and urine (80%) and to a minor extent via the faeces (10%). Of the 80% found in the urine, 38% is excreted as the parent drug and 37% as the ring-opened metabolite. The biological half-life is about 3.5 hours in women, 4.2 hours in men and 2.5 hours in children up to 12 years of age.
Sources: en.wikipedia.org
In 1977, the institute was officially affiliated to the Ministry of Scientific Research By June 1978 the TBRI's laboratories and out-patients clinic were inaugurated. The attached hospital was completed in December 1981, and the official opening was in 1983 according to Presidential Decree No. 58. The institute which started with 12 research departments and 120 bed hospital became this institution encompassing 20 research departments covering a wide spectrum of academic and clinical specialties divided into six divisions (Clinical Medical Division, clinical Surgical Division, Clinical Laboratory Research Division, Immunology &Therapeutic Evaluation Division, Biochemistry &Medicinal Chemistry Division, Medical Malacology & Environmental Research Division). The 20 departments are: Gastroenterology, Hepatology, Nephrology, Public Health, Radiology., Anaesthesia, Intensive care, Surgery, Urology, Clinical Chemistry, Electron Microscopy, Hematology, Microbiology, Pathology, Immunology, Parasitology, Pharmacology, Biochemistry, Medicinal Chemistry, Environmental Research and Medical Malacology departments.
They can also be made by the reaction of Lawesson's reagent with esters or by treating pinner salts with hydrogen sulfide. Various thionoesters may be prepared through the transesterification of an existing methyl thionoester with an alcohol under base-catalyzed conditions.
== Structure == Lumican is a proteoglycan Class II member of the small leucine-rich proteoglycan (SLRP) family that includes decorin, biglycan, fibromodulin, keratocan, epiphycan, and osteoglycin. Like the other SLRPs, lumican has a molecular weight of about 40 kilodaltons and has four major intramolecular domains:
Dogs, the first domesticated animal, have been used in hunting, in security and in warfare, as have horses, pigeons and birds of prey; while other terrestrial and aquatic animals are hunted for sports, trophies or profits. Non-human animals are also an important element of human culture, having appeared in cave arts and totems since the earliest times, and are frequently featured in mythology, religion, arts, literature, heraldry, politics, and sports.
==== Dislocation and subluxation management ==== When a dislocation or subluxation occurs, muscle spasms and stress tend to follow, increasing pain and reducing the chances of the dislocation/subluxation naturally relieving. Methods to support a joint after such an incident include the usage of a sling to hold the joint in place and allow it to relax. Orthopedic casts are not advised, as there could be pain if unrelaxed muscles are still trying to spasm out against the cast. Other solutions to promote relaxation are heat, gentle massaging, and mental distractions.
Sources: en.wikipedia.org
==== Integral fast reactor ==== One design of fast neutron reactor, specifically conceived to address the waste disposal and plutonium issues, was the integral fast reactor (IFR, also known as an integral fast breeder reactor, although the original reactor was designed to not breed a net surplus of fissile material). The IFR concept included on-site pyroprocessing to recycle used fuel. The remaining waste would not consist solely of short-lived fission products. Long-lived fission products such as technetium-99 and iodine-129 remain important for disposal, and pyroprocessing also generates waste streams containing salts and fuel cladding. Some fission products could later be separated for industrial or medical uses and the rest sent to a waste repository. The IFR pyroprocessing system uses molten cadmium cathodes and electrorefiners to reprocess metallic fuel directly on-site at the reactor. Such systems co-mingle all the minor actinides with both uranium and plutonium. The systems are compact and self-contained, so that no plutonium-containing material needs to be transported away from the site of the breeder reactor. Breeder reactors incorporating such technology would most likely be designed with breeding ratios very close to 1.00, so that after an initial loading of enriched uranium and/or plutonium fuel, the reactor would then be refueled only with small deliveries of natural uranium. A quantity of natural uranium equivalent to a block about the size of a milk crate delivered once per month would be all the fuel such a 1 gigawatt reactor would need.
Though many human rights note that Duterte's war on drugs was a stain on his legacy, the anti-narcotics drive received domestic approval during his term, and 58% of the country's barangays were declared by the government cleared of illegal drugs by February 2022.
Chest X-ray Atlas USUHS: Basic Chest X-Ray Review eMedicine Radiology: Chest articles Database of chest radiology related to emergency medicine Archived 2008-07-25 at the Wayback Machine Introduction to chest radiology: a tutorial for learning to read a chest x-ray Chest Radiology Tutorials Free Web Tutorials for Chest Anatomy and Lung Malignancies in Radiology Yale: Introduction to Cardiothoracic Imaging
=== Economy, development, and resource factors === A 2018 study found that "oil price shocks are seen to promote coups in onshore-intensive oil countries, while preventing them in offshore-intensive oil countries". The study argues that states which have onshore oil wealth tend to build up their military to protect the oil, whereas states do not do that for offshore oil wealth. A 2020 study found that elections had a two-sided impact on coup attempts, depending on the state of the economy. During periods of economic expansion, elections reduced the likelihood of coup attempts, whereas elections during economic crises increased the likelihood of coup attempts. A 2021 study found that oil wealthy nations see a pronounced risk of coup attempts but these coups are unlikely to succeed. On the contrary, a 2014 study of 18 Latin American countries in the 20th century found that coup frequency does not vary with development levels, economic inequality, or the rate of economic growth.
Sources: en.wikipedia.org
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.
Solid material is usually kept at -20 °C, desiccated, and protected from light. Dimethyl sulfoxide stocks should be stored cold and subjected to minimal freeze-thaw cycles. Aqueous solutions are generally less stable and should be prepared fresh when possible.
Legality depends on the country and the intended use. It is not an approved medicine, and some places restrict or ban sales for human consumption. Buyers should verify local rules and product documentation before procurement.
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.